Drug Approval | May 09, 2023
IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
New agreement applies to the polymers of the Medical Care series portfolio
Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22
Specialty Chemicals grew 38% YoY for FY23
Calibre will enhance the pace of new product development and the breadth of its Custom Development and Manufacturing (CDMO) Service offerings.
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The company completed paracetamol capacity expansion by 1,800 MTPA and the company is now focusing on frugal manufacturing practices to reduce raw material cost and expand margins
Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Subscribe To Our Newsletter & Stay Updated
